α 1A -and α 1B -adrenoceptors (ARs) are G protein-coupled receptors (GPCRs) that are activated by adrenaline and noradrenaline to modulate smooth muscle contraction in the periphery, and neuronal outputs in the central nervous system (CNS). α 1A -and α 1B -AR are clinically targeted with antagonists for hypertension and benign prostatic hyperplasia and are emerging CNS targets for treating neurodegenerative diseases. The benzodiazepines midazolam, diazepam, and lorazepam are proposed to be positive allosteric modulators (PAMs) of α 1 -ARs. Here, using thermostabilized, purified, α 1A -and α 1B -ARs, we sought to identify the benzodiazepine binding site and modulatory mechanism to inform the design of selective PAMs. However, using a combination of biophysical approaches no evidence was found for direct binding of several benzodiazepines to purified, stabilized α 1A -and α 1B -ARs. Similarly, in cellbased assays expressing unmodified α 1A -and α 1B -ARs, benzodiazepine treatment had no effect on fluorescent ligand binding, agonist-stimulated Ca 2+ release, or G protein activation. In contrast, several benzodiazepines positively modulated phenylephrine stimulation of a cAMP response element pathway by α 1A -and α 1B -ARs; however, this was shown to be caused by off-target inhibition of phosphodiesterases, known targets of diazepam. This study highlights how purified, stabilized
| INTRODUCTION
Adrenergic receptors, or adrenoceptors (ARs), are a family of G protein-coupled receptors (GPCRs) that bind endogenous adrenaline and noradrenaline and are important for modulating the cardiovascular and nervous systems. GPCRs are seven α-helical transmembrane (TM) proteins that bind ligands on the extracellular face shifting the conformational equilibria of the GPCR to active states and promoting cytoplasmic interactions with heterotrimeric G proteins and other signaling proteins. 1 There are three AR subfamilies, α 1 , α 2 , and β-ARs, each comprising three receptor subtypes. 2 The α 1 -AR subtypes, α 1A -AR, α 1B -AR, and α 1D -AR couple to Gα q/11 G proteins to activate phospholipase C-β (PLCβ) that catalyses the formation of the second messenger, inositol 1,4,5-trisphosphate (IP 3 ), thereby stimulating intracellular calcium mobilization. α 1 -AR signaling stimulates smooth muscle contraction and thus α 1 -AR antagonists are prescribed for hypertension and benign prostatic hyperplasia. 3 α 1A -AR and α 1B -AR are also highly expressed in the brain, and transgenic rodent models have indicated α 1A -AR activation stimulates neurogenesis, while prolonged α 1B -AR stimulation promotes apoptotic neurodegeneration. 3, 4 In the failing rodent heart, α 1A -AR stimulation drives adaptive hypertrophy, whereas chronic α 1B -AR activation causes maladaptive hypertrophy as a result of hemodynamic overload. 3 Thus, selective α 1A -AR activation, or α 1B -AR blockade, could be useful therapeutic strategies for certain diseases.
While there are some α 1A -AR and α 1B -AR subtype-selective ligands available, no highly α 1 -AR subtype-selective drugs have been approved for use in the clinic. The highly similar ligand binding sites in closely related AR subtypes makes identifying subtype-selective ligands challenging. Allosteric ligands, on the other hand, bind to distinct sites in the receptor and can modulate the activity of the receptor in response to agonist binding. As allosteric sites are less conserved between receptor subtypes it may be possible that allosteric modulators offer scope for achieving subtype selectivity. Several ligands have been reported to act as allosteric modulators of α 1A -AR and α 1B -AR, including the conotoxin ρ-TIA, 5 9-aminoacridine, 6 and the benzodiazepines diazepam, lorazepam, and midazolam. 7 However, the exact structural mechanisms by which these ligands modulate the receptors are unknown.
Benzodiazepines are positive allosteric modulators (PAMs) of GABA A R ion channels and are widely prescribed as sedatives, anxiolytics, anticonvulsants, and myorelaxants. 8 The benzodiazepines, diazepam and lorazepam, inhibit Ca 2+ oscillations in pulmonary artery smooth muscle cells, suggestive of off-target interactions with ARs. 9 Waugh et al. 7 postulated that benzodiazepines directly bind to We recently engineered thermostabilized mutants of α 1A -AR and α 1B -AR, which enabled binding epitope determination of orthosteric ligands with nuclear magnetic resonance (NMR) spectroscopy. 10 In this work we sought to use these thermostabilized receptors and our NMR approach to further understand how benzodiazepines bind to and modulate α 1 -ARs so as to apply this information as a starting point for developing more selective modulators targeting this allosteric site. Instead we observed no evidence for the direct binding of several benzodiazepines to purified α 1A -AR and α 1B -AR using NMR and fluorescent ligand binding assays. Cell-based binding and calcium signaling assays with wild-type (WT) α 1 -ARs also failed to detect any direct modulatory effects of diazepam on these receptors. While diazepam could positively modulate the stimulation of a cAMP response element (CRE) reporter through α 1 -AR activation, this was found to be driven through the ability of diazepam to inhibit phosphodiesterases (PDEs), a known target of some benzodiazepines. This study highlights how purified GPCRs can be used to directly investigate allosteric modulator mechanisms that have been proposed from cell-based assays, where off-target actions are difficult to control for.
| MATERIALS AND METHODS

| Benzodiazepine preparation
Nordiazepam and diazepam were synthesized from 2-amino-5-chlorobenzophenone using the method of Sternbarch et al. 11 N-hydro- 
| Data analysis
Nuclear magnetic resonance (NMR) data were processed in Topspin 3.5 using squared cosine-bells in both dimensions and zero-filled once, prior to Fourier-transformation. All other data was analyzed performed in triplicate wells and normalized to the peak response elicited by 3 μmol/L ionomycin. CRE assay was conducted in triplicate, and data were normalized to the response elicited by the vehicle. Curves were fitted with three variable nonlinear regressions. For GPR68 assays, responses were normalized to CRE response at pH 6.8 (100%) and pH 7.8 (0%).
| RESULTS
Previously the benzodiazepines lorazepam,diazepam, and midazolam were shown to behave as positive modulators of α 1 -AR agonists in cell lines overexpressing α 1 -ARs, with low micromolar potencies. 7 However, direct binding of benzodiazepines to purified α 1 -AR proteins has never been demonstrated. Thermostabilized GPCRs are receptors containing mutations that improve the protein stability upon solubilization and purification using detergents. 14 The retention of natural receptor pharmacology enables thermostabilized receptors to be used for structural biology 15 and for probing the mechanisms and kinetics of ligand binding in a purified system. 10, 13, 16 The thermostabilized variants α 1A -AR A4 and α 1B -AR #15 were recently described and exhibit the stability required to probe the binding of benzodiazepines to the purified receptors. 10 We hypothesized that if ligands or proteins. 17 We recently applied STD NMR to the study of orthosteric agonist binding at α 1A -AR A4 and α 1B -AR #15. azepines (0 to 50 μmol/L), had no effect in the absence (Figure 3D ), or presence of phenylephrine on both receptor expressing cell lines ( Figure 3E,F) . To gain a more complete measure of phenylephrineinduced α 1 -AR signaling over a 6-h stimulation period, a CREreporter gene assay was employed. In this assay, diazepam positively modulated the potency of phenylephrine at α 1A -AR and α 1B -AR expressing cells and also increased the E max of phenylephrine at α 1B -AR expressing cells ( Figure 4A ,B and Table 1 ). Diazepam modulated the phenylephrine CRE response with potencies of 6.5 ± 4.8 μmol/L on α 1A -AR and 7.8 ± 1.9 μmol/L on α 1B -AR (mean EC 50 ± SD from three experiments, Figure 4C ). Critically, diazepam treatment in the absence of phenylephrine did not induce a CRE response (Figure 4C) . However, diazepam positively modulated the phenylephrine-induced CRE response on COS-7 cells that do not express α 1A -AR and α 1B -AR ( Figure 4D ), suggesting that the action of diazepam on CRE signaling is independent of α 1 -AR stimulation. Table 1 .
F I G U R E 3
Interestingly, the N-methyl group of diazepam, which is lacking in nordiazepam, was found to be critical for positive modulation of the phenylephrine-induced CRE activation in α 1B -AR expressing COS-7 cells and forskolin stimulation of CRE in untransfected HEK cells ( Figure 5 and Table 1 ). Furthermore, the GABA A R-inactive benzodiazepine, 7-phenyl-diazepam, was able to modulate the phenylephrine-induced CRE activation, although its actions on forskolin failed to reach statistical significance ( Figure 5 and Table 1 ). This defined SAR indicated that the benzodiazepine mechanism driving this positive modulation of phenylephrine was likely being driven by a specific binding interaction with a target other than GABA A R in the cells rather than nonspecific interactions, for example, with the cell membrane.
Next, we sought to define the mechanism by which diazepam was modulating CRE activation by using inhibitors of various potential targets. Co-addition of the GABA A R antagonist bicuculline had no effect on the positive modulation of phenylephrine or forskolin by diazepam ( Figure 6A,B) . Voltage-gated calcium channels, through a CaM-dependent mechanism, are known to play a role in α 1 -ARinduced cAMP production and diazepam is thought to bind to some Ca 2+ channels. 23 Cotreatment of cells with the broad spectrum Ca Diazepam is an inhibitor of PDEs, especially PDE-4, 24 and thus should increase the levels of cAMP in cells during the CRE assay, potentially explaining our observations. In this case, we would expect co-addition of the broad-spectrum PDE inhibitor IBMX, or the PDE- The SAR governing benzodiazepine action at GABA A receptors is well understood. The substituent at C-7 is of paramount importance; small electron-withdrawing substituents at C-7 generally impart high activity, whereas electron donors or large groups are inactive. 27 Substitutions at N-1 in contrast are generally tolerated, even though pam, also lacked the ability to modulate the CRE response, but was recently found to positively modulate the pH-sensitive GPCR and GPR68. Here, we confirmed the activity of lorazepam upon GPR68
using the CRE assay and demonstrated that its activity is not due to PDE inhibition. Notably, lorazepam induced a significantly higher GPR68-induced CRE response than diazepam or rolipram treatment.
Interestingly, diazepam did not significantly increase the CRE response of GPR68 at pH 7.2, suggesting that GPR68 stimulates CRE in a different, more robust way to α 1 -ARs. This may be related to the fact that GPR68 can couple to Gs proteins to directly activate cAMP accumulation, and thus CRE, 25 whereas α 1 -ARs stimulate CRE indirectly through Gq.
In summary, this work shows the value of stabilized, purified α 1 -ARs to probe direct molecular interactions, allowing us to show that the modulation of α 1 -AR activity by benzodiazepines in cell-based assays is not a result of direct ligand binding. We further demonstrated that significant modulation of cellular CRE responses by diazepam most likely occurred through inhibition of PDE-4. Given the widespread use of benzodiazepines therapeutically, this off-target effect may contribute to their clinical actions and side effects and warrants further study. In contrast to this, lorazepam was validated as a direct-acting, PAM of the pH sensitive receptor GPR68.
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